Loading...

Romain Pacaud, PhD

TitlePostdoctoral Scholar
SchoolUCSF School of Medicine
DepartmentMedicine
Address1450 Third St
San Francisco CA 94158
Phone415-476-5783
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    Nantes University (France)PhD2016Medicine

    Collapse Overview 
    Collapse Interests

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Cheray M, Pacaud R, Nadaradjane A, Oliver L, Vallette FM, Cartron PF. Specific Inhibition of DNMT3A/ISGF3? Interaction Increases the Temozolomide Efficiency to Reduce Tumor Growth. Theranostics. 2016; 6(11):1988-1999. PMID: 27698935.
      View in: PubMed
    2. Pacaud R, Cheray M, Nadaradjane A, Vallette FM, Cartron PF. Histone H3 phosphorylation in GBM: a new rational to guide the use of kinase inhibitors in anti-GBM therapy. Theranostics. 2015; 5(1):12-22. PMID: 25553095; PMCID: PMC4265745.
    3. Pacaud R, Sery Q, Oliver L, Vallette FM, Tost J, Cartron PF. DNMT3L interacts with transcription factors to target DNMT3L/DNMT3B to specific DNA sequences: role of the DNMT3L/DNMT3B/p65-NF?B complex in the (de-)methylation of TRAF1. Biochimie. 2014 Sep; 104:36-49. PMID: 24952347.
      View in: PubMed
    4. Pacaud R, Brocard E, Lalier L, Hervouet E, Vallette FM, Cartron PF. The DNMT1/PCNA/UHRF1 disruption induces tumorigenesis characterized by similar genetic and epigenetic signatures. Sci Rep. 2014 Mar 18; 4:4230. PMID: 24637615; PMCID: PMC3957150.
    5. Cheray M, Pacaud R, Nadaradjane A, Vallette FM, Cartron PF. Specific inhibition of one DNMT1-including complex influences tumor initiation and progression. Clin Epigenetics. 2013 Jun 28; 5(1):9. PMID: 23809695; PMCID: PMC3727981.
    Back to TOP